Results 71 to 80 of about 5,456,142 (288)

From NAFLD to MASLD – a new approach for the definition of fatty liver disease associated with metabolic dysfunction

Studia Medyczne
Metabolic dysfunction-associated steatotic liver disease (MASLD) is common, affecting a quarter of the population. The pathogenesis of this disease is multifactorial and has been well known for years. After 40 years of using the binding definition of non-
Iwona Gorczyca-Głowacka, Łukasz Nawacki, Magdalena Dolecka-Ślusarczyk, Agnieszka Ciba-Stemplewska, Stanisław Głuszek   +4 more
doaj   +1 more source

Temporal Change Rate in Sound Velocity Caused by Ultrasonic Heating for Evaluation of Steatotic Liver

Biology
Steatotic liver diseases are increasing globally, with metabolic dysfunction-associated steatohepatitis potentially causing irreversible fibrosis progression.
Machi Itsubo, Yume Kobayashi, Masaki Yamamoto, Shinji Takayanagi, Iwaki Akiyama   +4 more
doaj   +1 more source

Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee. [PDF]

, 2011
This review summarizes the document elaborated by the Italian Association for the Study of the Liver (AISF) ad hoc committee "Vascular disorders of the liver" on the primary circulatory liver diseases, which include Budd-Chiari syndrome, obstruction of ...
Riggio O, Sacerdoti D, Senzolo M, Primignani M, Italian Association for the Study of the Liver AISF ad hoc committee Vascular disorders of the liver, SACERDOTI, DAVID   +5 more
core   +1 more source

Surgically confirmed severe endometriosis is associated with lower risk of steatotic liver disease: Evidence of estrogen‐linked hepatic–reproductive crosstalk

International Journal of Gynecology &Obstetrics, EarlyView.
Severe surgically confirmed endometriosis was associated with a lower prevalence of steatotic liver disease than non‐severe disease. Higher estradiol levels may partly explain this inverse hepatic–reproductive association, supporting integrated gynecologic and hepatologic risk assessment.
Jung Hyun Park, Keungmo Yang, Hyun Yang, Si Hyun Bae, Mee‐Ran Kim, Jaejun Lee   +5 more
wiley   +1 more source

Hyperuricemia—Especially “Metabolic Hyperuricemia”—Is Independently Associated with a Higher Risk of Steatotic Liver Disease

Metabolites
Background: Hyperuricemia and steatotic liver disease are both associated with various comorbidities and mortality. This study was carried out to study the association between hyperuricemia and steatotic liver disease and to assess the impact of the ...
Janis Timsans, Jenni Kauppi, Vappu Rantalaiho, Anne Kerola, Kia Hakkarainen, Mika Paldanius, Hannu Kautiainen, Markku Kauppi   +7 more
doaj   +1 more source

Harnessing fluorescence microscopy to elucidate the mechanisms of metabolic dysfunction-associated steatotic liver disease

Metabolic dysfunction-associated steatotic liver disease is defined by hepatic lipid overload resulting in a metabolic shift and subsequent mitochondrial impairment.
Purdie, Kaitlyn
core   +1 more source

Redefining Fatty Liver Disease: How Updated Nomenclature Reshapes Clinical Laboratory Diagnostics

iLABMED, EarlyView.
The transition from nonalcoholic fatty liver disease (NAFLD) to metabolic dysfunction‐associated steatotic liver disease (MASLD) reorients laboratory diagnosis from exclusion‐based rules toward metabolic and inflammatory biomarkers. This review compares their diagnostic criteria, epidemiology, insulin resistance mechanisms, imaging, and key laboratory ...
Ran Wei, Yuanyue Guan, Meiqing Zhai, Xiuying Zhao   +3 more
wiley   +1 more source

Metabolic Dysfunction-Associated Steatotic Liver Disease MASLD: Jordan’s Perspective Based on Knowledge and Attitude Determinants [PDF]

Omar Alqudah,1 Hamzeh Feras Alshahwan,2,* Jehad Feras Alsamhouri,2,* Saif Yamin,2,* Ahmad Kaffaf,2,* Mohannad Alassaf,2,* Zaid Alwarawrah3 1Department of Medicine, Division of Hepatology and Gastroenterology, Jordan University ...
Kaffaf A, Alassaf M, Alshahwan HF, Alqudah O, Alsamhouri JF, Yamin S, Alwarawrah Z   +6 more
core  

Human biomarker navigator

iMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li, Qian Zhang, Zijie Wang, Zeping Gui, Jing Liu, Jingda Li, Maojun Jiang, Zukang Chang, Qingqing Han, Bendong Yang, Tariq Saeed, Jun Li, Jinghan Jia, Chenghu Song, Tong Shao, Tianhuan Peng, Xueying Zhang, Pingping Guo, Jun Luo, Gangao Yang, Yuan Wan, Gokhan Zengin, Quan Yuan, Lingru Li, Xiaohui Fan, Yang Luo, Lvyun Zhu, Yanfei Zheng, Wenjun Mao, Wenlong Sun   +29 more
wiley   +1 more source

Non‐Nutritive Artificial Sweeteners Aspartame and Acesulfame‐K Ameliorate Metabolic Dysfunction‐Associated Steatotic Liver Disease in Male Ldlr−/− Mice

iNew Medicine, EarlyView.
ABSTRACT Aspartame and acesulfame‐K are commonly used non‐nutritive artificial sweeteners, but their impacts on cardiovascular disease and metabolic dysfunction‐associated fatty liver disease (MASLD) are unclear. In this study, we evaluated the impacts of aspartame and acesulfame‐K on MASLD and atherosclerosis in male Ldlr−/− mice fed an AMLN diet ...
Jingjing Xu, Xiaohua Jiang, Jianping Weng, Suowen Xu   +3 more
wiley   +1 more source